SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001477932-17-003029
Filing Date
2017-06-28
Accepted
2017-06-28 11:15:56
Documents
1
Group Members
BRI-MEL HOLDINGS LTD.BRIAN SKIDMOREMELANIE SKIDMORE

Document Format Files

Seq Description Document Type Size
1 SC 13G imnp_sc13g.htm SC 13G 51433
  Complete submission text file 0001477932-17-003029.txt   52859
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Subject) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82315 | Film No.: 17934299
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 370 MILNER A1 V0X 1T0
Business Address
Skidmore Brian (Filed by) CIK: 0001710223 (see all company filings)

Type: SC 13G